OBJECTIVE: Thyroid nodules are a common finding in the general population. The primary aim of the study was to determine the prevalence of thyroid nodules and cancer found by ultrasound (US) in women who underwent screening for thyroid dysfunction during pregnancy. DESIGN: A double-centric, retrospective, cohort study. PATIENTS AND METHODS: We searched through medical records, including thyroid ultrasonography, of pregnant women who were positively screened for thyroid disorders (using thyroid-stimulating hormone and thyroid antibodies) from an unselected population ('universal screening group', n = 690) and of women who underwent the testing based on the presence of clinical risk factors defined by American Thyroid Association ('case-finding group', n = 249). RESULTS: Prevalence of benign and malignant thyroid nodules was lower in the 'universal screening group' than in the 'case-finding group' (9.9% vs 17.7%, P= 0.002, and 0.9% vs 7.2%, P< 0.001, respectively). Consistently, the thyroid cancer rate was lower among the nodules in the 'universal screening group' than in the 'case-finding group' (8.1% vs 29.0%, P= 0.003). Ultrasound EU-TIRADS (European Thyroid Imaging and Reporting Data System) category ≥4 had a 95.8% sensitivity for thyroid cancer. In palpable nodules, the prevalence of cancer was significantly higher than in the non-palpable ones (44.0% vs 2.2%, P < 0.001). In a multivariate regression analysis, thyroid nodules were associated with a history of infertility and parity. CONCLUSIONS: Compared to the data from cancer registries, universal screening allowed detecting thyroid cancer in pregnancy three to five times more frequently, but the cancer rate among nodules (8.1%) did not differ from the common population. US had very good sensitivity for thyroid cancer in pregnancy.

3rd Department of Medicine 1st Faculty of Medicine Charles University General University Hospital Prague Czech Republic

4th Department of Medicine Faculty of Medicine Charles University University Hospital Hradec Králové Czech Republic

Department of Clinical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University General University Hospital Prague Czech Republic

Department of Nuclear Medicine District Hospital Havlíčkův Brod Czech Republic

Zobrazit více v PubMed

Glinoer D, Soto MF, Bourdoux P, Lejeune B, Delange F, Lemone M, Kinthaert J, Robijn C, Grun JP, de Nayer P. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. Journal of Clinical Endocrinology and Metabolism 199173421–427. (10.1210/jcem-73-2-421) PubMed DOI

Kung AW, Chau MT, Lao TT, Tam SC, Low LC. The effect of pregnancy on thyroid nodule formation. Journal of Clinical Endocrinology and Metabolism 2002871010–1014. (10.1210/jcem.87.3.8285) PubMed DOI

Struve CW, Haupt S, Ohlen S. Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease. Thyroid 199337–9. (10.1089/thy.1993.3.7) PubMed DOI

Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. American Journal of Obstetrics and Gynecology 20031891128–1135. (10.1067/s0002-9378(0300537-4) PubMed DOI

Yasmeen S, Cress R, Ramano PS, Xing G, Berger Chen S, Danielsen B, Smith LH. Thyroid cancer in pregnancy. International Journal of Gynaecology and Obstetrics 20059115–20. (10.1016/j.ijgo.2005.06.022) PubMed DOI

Rosen IB, Walfish PG, Nikore V. Pregnancy and surgical thyroid disease. Surgery 1985981135–1140. PubMed

Tan GH, Gharib H, Goellner JR, van Heerden JA, Bahn RS. Management of thyroid nodules in pregnancy. Archives of Internal Medicine 19961562317–2320. (10.1001/archinte.1996.00440190059007) PubMed DOI

Marley EF, Oertel YC. Fine-needle aspiration of thyroid lesions in 57 pregnant and postpartum women. Diagnostic Cytopathology 199716122–125. (10.1002/(sici)1097-0339(199702)16:2<122::aid-dc5>3.0.co;2-j) PubMed DOI

Hannibal CG, Jensen A, Sharif H, Kjaer SK. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Human Reproduction 200823451–456. (10.1093/humrep/dem381) PubMed DOI

Reigstad MM, Storeng R, Myklebust TÅ, Oldereid NB, Omland AK, Robsahm TE, Brinton LA, Vangen S, Furu K, Larsen IK. Cancer risk in women treated with fertility drugs according to parity status – a registry-based cohort study. Cancer Epidemiology, Biomarkers and Prevention 201726953–962. (10.1158/1055-9965.EPI-16-0809) PubMed DOI PMC

Ding DC, Chen W, Wang JH, Lin SZ, Sung FC. Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan. Cancer 20191251701–1708. (10.1002/cncr.31964) PubMed DOI

Yeo Y, Ma SH, Hwang Y, Horn-Ross PL, Hsing A, Lee KE, Park YJ, Park DJ, Yoo KY, Park SK. Diabetes mellitus and risk of thyroid cancer: a meta-analysis. PLoS ONE 20149 e98135. (10.1371/journal.pone.0098135) PubMed DOI PMC

Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJet al.2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 201727315–389. (10.1089/thy.2016.0457) PubMed DOI

Russ G, Bonnema SJ, Erdogan MF, Durante C, Ngu R, Leenhardt L. European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. European Thyroid Journal 20176225–237. (10.1159/000478927) PubMed DOI PMC

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger Met al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016261–133. (10.1089/thy.2015.0020) PubMed DOI PMC

Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of Cancer Epidemiology 20132013965212. (10.1155/2013/965212) PubMed DOI PMC

Welch HG, Kramer BS, Black WC. Epidemiologic signatures in cancer. New England Journal of Medicine 20193811378–1386. (10.1056/NEJMsr1905447) PubMed DOI

Fiddes JC, Goodman HM. The gene encoding the common alpha subunit of the four human glycoprotein hormones. Journal of Molecular and Applied Genetics 198113–18. PubMed

Alves VG, Santin PA, Furlanetto WT. Prognosis of thyroid cancer related to pregnancy: a systematic review. Journal of Thyroid Research 2011101–5. (10.4061/2011/691719) PubMed DOI PMC

Murgia F, Marinaccio M, Cormio G, Loizzi V, Cicinelli R, Bettocchi S, Cicinelli E. Pregnancy related cancer in Apulia. A population based linkage study. European Journal of Obstetrics and Gynecology and Reproductive Biology: X 20193100025. (10.1016/j.eurox.2019.100025) PubMed DOI PMC

Hagag P, Strauss S, Weiss M. Role of ultrasoundguided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules. Thyroid 19988989–995. (10.1089/thy.1998.8.989) PubMed DOI

Negri E, Dal Maso L, Ron E, La Vecchia C, Mark SD, Preston-Martin S, McTiernan A, Kolonel L, Yoshimoto Y, Jin Fet al.A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes and Control 199910143–155. (10.1023/a:1008880429862) PubMed DOI

Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, Bernstein L. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiology, Biomarkers and Prevention 2011201751–1759. (10.1158/1055-9965.EPI-11-0381) PubMed DOI PMC

Zamora-Ros R, Rinaldi S, Biessy C, Tjønneland A, Halkjaer J, Fournier A, Boutron-Ruault MC, Mesrine S, Tikk K, Fortner RTet al.Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study. International Journal of Cancer 20151361218–1227. (10.1002/ijc.29067) PubMed DOI

Zhou YQ, Zhou Z, Qian MF, Gong T, Wang JD. Association of thyroid carcinoma with pregnancy: a meta-analysis. Molecular and Clinical Oncology 20153341–346. (10.3892/mco.2014.472) PubMed DOI PMC

Mazzaferii EL.Approach to the pregnant patient with thyroid cancer. Journal of Clinical Endocrinology and Metabolism 201196265–272. (10.1210/jc.2010-1624) PubMed DOI

Yu Q, Lv X, Liu K, Ma D, Wu Y, Dai W, Jiang H. Fertility drugs associated with thyroid cancer risk: a systematic review and meta-analysis. BioMed Research International 201820187191704. (10.1155/2018/7191704) PubMed DOI PMC

Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, Serr D. Cancer incidence in a cohort of infertile women. American Journal of Epidemiology 1987125780–790. (10.1093/oxfordjournals.aje.a114595) PubMed DOI

Althuis MD, Scoccia B, Lamb EJ, Moghissi KS, Westhoff CL, Mabie JE, Brinton LA. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. American Journal of Obstetrics and Gynecology 2005193668–674. (10.1016/j.ajog.2005.01.091) PubMed DOI

Calderon-Margalit R, Friedlander Y, Yanetz R, Kleinhaus K, Perrin MC, Manor O, Harlap S, Paltiel O. Cancer risk after exposure to treatments for ovulation induction. American Journal of Epidemiology 2009169365–375. (10.1093/aje/kwn318) PubMed DOI PMC

Yli-Kuha AN, Gissler M, Klemetti R, Luoto R, Hemminki E. Cancer morbidity in a cohort of 9175 Finnish women treated for infertility. Human Reproduction 2012271149–1155. (10.1093/humrep/des031) PubMed DOI

Martinez M, Rabadan S, Domingo J, Cobo A, Pellicer A, Garcia-Velasco JA. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. Reproductive Biomedicine Online 201429722–728. (10.1016/j.rbmo.2014.09.002) PubMed DOI

Reigstad MM, Larsen IK, Myklebust TÅ, Robsahm TE, Oldereid NB, Omland AK, Vangen S, Brinton LA, Storeng R. Cancer risk among parous women following assisted reproductive technology. Human Reproduction 2015301952–1963. (10.1093/humrep/dev124) PubMed DOI PMC

Seo YG, Choi HC, An AR, Park DJ, Park YJ, Lee KE, Park SK, Hwang Y, Cho B. The association between type 2 diabetes mellitus and thyroid cancer. Journal of Diabetes Research 201720175850879. (10.1155/2017/5850879) PubMed DOI PMC

Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. Journal of Clinical Endocrinology and Metabolism 2006914295–4301. (10.1210/jc.2006-0527) PubMed DOI